What is Celestial Biolabs Ltd. Quarterly Revenue?

Celestial Biolabs Ltd. Quarterly Revenue Celestial Biolabs Dec-2023 Quarterly Revenue is Rs 0 Cr which is growth of 8.9% YoY.

What is Celestial Biolabs Ltd. Quarterly Net Profit?

Celestial Biolabs Ltd. Quarterly Net Profit Celestial Biolabs Dec-2023 Quarterly Net Profit is Rs -0 Cr which is growth of 77.5% YoY.

What is Celestial Biolabs Ltd. Annual Revenue?

Celestial Biolabs Ltd. Annual Revenue Celestial Biolabs Mar-2023 Annual Revenue is Rs 0 Cr which is growth of 14.4% YoY.

What is Celestial Biolabs Ltd. Annual Net Profit?

Celestial Biolabs Ltd. Annual Net Profit Celestial Biolabs Mar-2023 Annual Net Profit is Rs -1 Cr which is growth of -39.7% YoY.

What is Celestial Biolabs Ltd. Total Shareholders Fund?

Celestial Biolabs Ltd. Total Shareholders Fund Celestial Biolabs Mar-2023 Total Shareholders Fund is Rs 3 Cr which is growth of -17.1% YoY.

What is Celestial Biolabs Ltd. Total Assets?

Celestial Biolabs Ltd. Total Assets Celestial Biolabs Mar-2023 Total Assets is Rs 17 Cr which is growth of -0.8% YoY.

What is Celestial Biolabs Ltd. Book Value Per Share?

Celestial Biolabs Ltd. Book Value Per Share Celestial Biolabs Mar-2023 Book Value Per Share is 1 Rs which is growth of -17.1% YoY.

What is Celestial Biolabs Ltd. ROE?

Celestial Biolabs Ltd. ROE Celestial Biolabs Mar-2023 ROE is -21% which is growth of 8.4% YoY.

What is Celestial Biolabs Ltd. Cash From Operating Activity?

Celestial Biolabs Ltd. Cash From Operating Activity Celestial Biolabs Mar-2023 Cash From Operating Activity is Rs -0 Cr which is growth of -25.6% YoY.

What is Celestial Biolabs Ltd. Net Cash Flow?

Celestial Biolabs Ltd. Net Cash Flow Celestial Biolabs Mar-2023 Net Cash Flow is Rs 0 Cr which is growth of 178.6% YoY.

Celestial Biolabs Ltd.

NSE: CELESTIAL | BSE: 532871

Portfolio

Alert

My Notes

Celestial Biolabs quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Celestial Biolabs quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Celestial Biolabs Dec-2023 Quarterly Revenue is Rs 0 Cr which is growth of 8.9% YoY.
POSITIVE
Quarterly Net Profit Celestial Biolabs Dec-2023 Quarterly Net Profit is Rs -0 Cr which is growth of 77.5% YoY.

Celestial Biolabs Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Dec '23	Mar '23	Dec '22	Sep '22	Jun '22	Mar '22	Dec '21	Sep '21	Jun '21	Jun '19	Mar '19	Dec '18	Sep '18
TOTAL_SR_Q Total Rev. ⌄	0	0	0	0	0.1	0.1	0	0.1		4.3	3.3	12.5	16.8
SR_Q Operating Rev.	0	0	0	0	0.1	0.1	0	0.1		4.3	3	12.5	16.8
OI_Q Other Income										0	0.4		0
OEXPNS_Q Operating Exp.	0.1	0.3	0.2	0.1	0.2	0.3	0.1	0.1	0.1	2.9	-0.8	10.5	14.1
OEXPNS_Q Operating Exp.	0.1	0.3	0.2	0.1	0.2	0.3	0.1	0.1	0.1	2.9	-0.8	10.5	14.1
OP_Q Operating Profit	-0	-0.2	-0.1	-0.1	-0.1	-0.3	-0	-0	-0.1	1.4	3.8	2	2.8
OPMPCT_Q Operating Profit Margin %	-76.90%	-601.58%	-428.99%	-177.51%	-169.69%	-425.04%	-111.60%	-47.72%	-	31.62%	127.17%	16.06%	16.33%
DEP_Q Depr.	0	0	0	0	0	0	0	0	0	2.2	3.7	1.9	1.9
INT_Q Interest										0.1	1		0.3
PBT_Q Profit Before Tax	-0	-0.2	-0.2	-0.1	-0.1	-0.3	-0.1	-0	-0.1	-1	-0.5	0.1	0.6
TAX_Q Tax
NP_Q Net Profit	-0	-0.2	-0.2	-0.1	-0.1	-0.3	-0.1	-0	-0.1	-1	-0.5	0.1	0.6
EPS_adj_Q EPS Adj. latest	-0	-0.1	-0.1	-0	-0	-0.1	-0	-0	-0	-0.4	-0.2	0	0.3
NP_TTM Net profit TTM	-	-0.6	-0.6	-0.5	-0.5	-0.4	-	-	-	-0.9	1.4	3.6	4.2
EPS_TTM Basic EPS TTM	-	-0.3	-0.3	-0.2	-0.2	-0.2	-	-	-	-0.4	0.6	1.6	1.9
results_pdf Results PDF
result_notes Result Notes			Notes	Notes						Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Celestial Biolabs competitor comparison and performance snapshot within industry

Celestial Biolabs annual results: revenue, profit, P&L, and margins as of Mar 2023 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Celestial Biolabs Mar-2023 Annual Revenue is Rs 0 Cr which is growth of 14.4% YoY.
NEGATIVE
Annual Net Profit Celestial Biolabs Mar-2023 Annual Net Profit is Rs -1 Cr which is growth of -39.7% YoY.

Celestial Biolabs Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16	Mar '15	Mar '14	Mar '13
SR_A Total Rev. Ann. ⌄	-66.5%	-65.8%	0.2	0.2	0	5.3	49.3	42.8	38.7	33.1	27.5	23.5	21.2
TotalOperatingRevenues_A Operating Rev. Ann.	-66.2%	-65.8%	0.2	0.2		5.2	49	42.8	38.7	32.9	27.5	23.5	21.2
OI_A Other Income Ann.	-	-			0	0	0.4			0.3			0
OEXPNS_A Operating Exp. Ann.	-81%	-53.1%	0.7	0.5	0.2	101.3	37.2	31	31.7	24.3	15	15.8	15.5
OEXPNS_A Operating Exp. Ann.	-81%	-53.1%	0.7	0.5	0.2	101.3	37.2	31	31.7	24.3	15	15.8	15.5
OP_A Operating Profit Ann.	-	-	-0.5	-0.4	-0.2	-96.1	11.7	11.8	7	8.6	12.4	7.8	5.7
OPMPCT_A OPM Ann. %	-	-	-320.87%	-256.68%	-541.81%	-1,822.73%	23.80%	27.63%	18.10%	25.81%	45.30%	32.98%	26.84%
TotalExpenses_A Total Exp. Ann. ⌄	-81.2%	-55.2%	0.7	0.6	0.2	105	47.9	38.7	35	31.3	26.2	23	20.9
OtherExpenses_A Other Exp. Ann.	-64.3%	-25.1%	0.4	0.3	0.1	8.8	7.1	1.7	2.9	4.4	8.1	5.7	5.5
EmployeeBenefitExpenses_A Employee Exp. Ann.	-12.6%	-19.7%	0.2	0.1	0	0.3	1.5	0.6	1.1	1	1	0.9	1.1
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	-	-	-0.5	-0.4	-0.1	-96.1	12.1	11.8	7	8.8	12.4	7.8	5.7
EBIDTPCT_A EBITDA Ann. margin %	-	-	-320.87%	-256.68%	-441.81%	-1,821.89%	24.52%	27.63%	18.10%	26.68%	45.30%	32.98%	27.03%
INT_A Interest Ann.	-	-				1.4	1.3	0	0	1.3	4.2	2.2	0.7
DEP_A Depr.	-	-	0	0	0	2.3	9.4	7.7	3.3	5.7	7.1	5	4.7
PBT_A PBT Ann.	-	-	-0.6	-0.4	-0.2	-99.8	1.4	4.1	3.7	1.9	1.2	0.6	0.3
TAX_A Tax Ann.	-	-				-1.4	1.4	0.7	0.3	-0.2	-0.1	-0.3	-0.4
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	-	-	-0.6	-0.4	-0.2	-98.3	-0	3.5	3.3	2.1	1.3	0.8	0.7
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	-	-	-0.6	-0.4	-0.2	-98.3	-0	3.5	3.3	2.1	1.3	0.8	0.7
NETPCT_A NPM Ann. %	-	-	-339.00%	-277.62%		-1,880.91%	-0.05%	8.07%	8.62%	6.33%	4.72%	3.59%	3.34%
EPS_adj_A EPS Adj. latest Ann.	-	-	-0.3	-0.2	-0.1	-43.5	-0	1.5	1.5	0.9	0.6	0.4	0.3
result_notes Result Notes							Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

3Y CAGR

-66.5%

5Y CAGR

-65.8%

7Y CAGR

-51.8%

10Y CAGR

-37.3%

Total Revenue Annual growth is higher than historical averages.

Operating Exp. Ann.

1Y CHG

40%

2Y CAGR

87.1%

3Y CAGR

-81%

5Y CAGR

-53.1%

7Y CAGR

-39.8%

10Y CAGR

-26.6%

Operating Expenses Annual Cr growth is higher than historical averages.

Celestial Biolabs balance sheet as of Mar 2023: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Total Shareholders Fund Celestial Biolabs Mar-2023 Total Shareholders Fund is Rs 3 Cr which is growth of -17.1% YoY.
NEGATIVE
Total Assets Celestial Biolabs Mar-2023 Total Assets is Rs 17 Cr which is growth of -0.8% YoY.

Celestial Biolabs Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16	Mar '15	Mar '14	Mar '13
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	-10.5%	-51.3%	2.8	3.4	3.8	3.9	102.3	102.3	98.8	90.1	86.6	85.6	79.3
EQCAP_A Equity Share Capital Ann.	0%	0%	22.6	22.6	22.6	22.6	22.6	22.6	22.6	20.5	18.6	17.4	14.6
TotalShareCapital_A Total Share Capital Ann.	0%	0%	22.6	22.6	22.6	22.6	22.6	22.6	22.6	20.5	18.6	17.4	14.6
ReservesAndSurplus_A Reserves Plus Surplus Ann.	-	-	-19.8	-19.2	-18.8	-18.7	79.7	79.7	76.3	69.6	62.3	68.3	64.7
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	-	-	-19.8	-19.2	-18.8	-18.7	79.7	79.7	76.3	69.6	62.3	68.3	64.7
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	2.8%	-1.1%	8.9	8.5	8.2	8.2	9.2	9.4	8.4	7.8	11.1	18.3	15.4
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-					1.4	-0	0.1	-0.5	-0.1	-0.2	0.2
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-	-
CL_A Total Current Liabilities Ann. ⌄	1.9%	18.6%	5.4	5.3	5.2	5.1	7.8	2.3	1.4	1.7	1.4	0.6	0.6
TradePayables_A Trade Payables Ann.	0%	-5.6%	0.3	0.3	0.4	0.3	0.6	0.4	0.4	0.7	0.7	0.4	0.3
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-23.6%	47.6%	2.1	2	1.8	4.7	5.8	0.3	0.2	0.6	0.5	0.1	0.3
ShortTermProvisions_A ST Provisions Ann.	-	-				0.1	1.5	1.6	0.8	0.5	0.3	0.1	0.1
TL_A Total Capital Plus Liabilities Ann.	-0.6%	-31.7%	17	17.2	17.2	17.3	119.3	114	108.6	105	99.1	104.4	95.3
FixedAssets_A Fixed Assets Ann. ⌄	-0.3%	-31%	12.9	12.9	12.9	13	96.8	82.7	90.4	56	53	61.5	61.9
TangibleAssets_A Tangible Assets Ann.	-20.6%	-62.1%	0.1	0.1	0.1	0.2	12.2	12.8	13.3	14.1	27.8	36.8	39.3
IntangibleAssets_A Intangible Assets Ann.	-	-					39.4	40.3	47.6	12.3
CapitalWorkInProgress_A Capital Work In Progress Ann.	0%	-15.4%	12.8	12.8	12.8	12.8	29.6	29.6	29.6	29.6	25.2	24.7	22.6
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	-0.3%	-31.1%	12.9	12.9	12.9	13	96.8	83	90.7	56.3	53	61.5	61.9
NonCurrentInvestments_A Non Current Investments Ann.	-	-								0.3
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-	-						0.3	0.3
CA_A Total Current Assets Ann. ⌄	-1.6%	-33.3%	4.1	4.3	4.2	4.3	22.6	31	17.8	48.7	46.1	42.9	33.4
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	-0.9%	-29.2%	3.7	3.8	3.8	3.8	15.6	20.8	8.3	12	9	9	5.8
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-	-	0		0	0	0.1	0	0.4	0.9	0.9	0.6	0.2
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-						0.7	0.7	1.5	0.8	0.7	1.4
OtherCurrentAssets_A Other Current Assets Ann.	0%	-41%	0.4	0.4	0.4	0.4	0.8	5.6	0.8	24.7	22.8	25.3	20.8
TA_A Total Assets Ann.	-0.6%	-31.7%	17	17.2	17.2	17.3	119.3	114	108.6	105	99.1	104.4	95.3
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-										4.2	6.9
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

-1.2%

2Y CAGR

-0.6%

3Y CAGR

-0.6%

5Y CAGR

-31.7%

7Y CAGR

-22.9%

10Y CAGR

-15.8%

Total Assets Annual is falling faster than historical averages.

Total Current Liabilities Ann.

1Y CHG

1.9%

2Y CAGR

1.9%

3Y CAGR

1.9%

5Y CAGR

18.6%

7Y CAGR

18%

10Y CAGR

24.6%

Total Current Liabilities Annual Cr growth is lower than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

-17.6%

2Y CAGR

-14.2%

3Y CAGR

-10.5%

5Y CAGR

-51.3%

7Y CAGR

-39.1%

10Y CAGR

-28.4%

Total ShareHolders Funds Annual is falling faster than historical averages.

Celestial Biolabs ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2023 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Book Value Per Share Celestial Biolabs Mar-2023 Book Value Per Share is 1 Rs which is growth of -17.1% YoY.
POSITIVE
ROE Celestial Biolabs Mar-2023 ROE is -21% which is growth of 8.4% YoY.

Celestial Biolabs Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16	Mar '15	Mar '14	Mar '13
BVSH_A BVSH Ann.	-11%	-51.6%	1.2	1.5	1.7	1.7	45.3	45.3	43.8	44	46.7	49.3	54.3
ROA_A RoA Ann. %	-	-	-3.35%	-2.38%	-0.99%	-570.23%	-0.02%	3.03%	3.07%	1.98%	1.30%	0.80%	0.74%
ROE_A ROE Ann. %	-	-	-20.58%	-12.22%	-4.55%	-2,501.50%	-0.02%	3.37%	3.37%	2.30%	1.49%	0.98%	0.89%
ROCE_A ROCE Ann. %	-	-	-4.89%	-3.45%	-1.42%	-811.73%	2.38%	3.70%	3.44%	3.03%	5.50%	2.66%	1.05%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-	-	-320.86%	-256.67%		-1,837.25%	24.69%	27.62%	18.09%	26.91%	45.29%	32.98%	27.08%
PBITMargin_A EBIT Ann. Margin %	-	-	-337.64%	-277.15%		-1,880.45%	5.41%	9.65%	9.55%	9.55%	19.58%	11.78%	4.71%
PBTMargin_A PBT Ann. Margin %	-	-	-339.00%	-277.62%		-1,907.79%	2.86%	9.59%	9.50%	5.63%	4.47%	2.35%	1.47%
NETPCT_A NPM Ann. %	-	-	-339.00%	-277.62%		-1,880.91%	-0.05%	8.07%	8.62%	6.33%	4.72%	3.59%	3.34%
ASETTO_A Asset Turnover Ann. %	-	-	0	0	-	0.1	0.4	0.4	0.4	0.3	0.3	0.2	0.2
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	0%	-43.3%	0.8	0.8	0.8	0.8	2.9	13.7	13.2	28.7	32	77.3	53.7
QuickRatio_A Quick Ratio Ann.	0%	-41.8%	0.8	0.8	0.8	0.8	2.1	12	7.5	23	23.2	64.2	45.2
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-			-	-
EarningRetention_A Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	9.1%	-15.8%	16.5	16.1	15.8	12.7	20.8	39.1	66.3	55.8	120.5	55.7	30.3
EVPerNetSales_A EV Per Net Sales Ann.	243.9%	155.3%	97.6	109.2		2.4	0.4	0.9	1.7	1.7	4.4	2.4	1.4
PBV_A Price To Book Value Adjusted	12%	104.2%	1.42	1.18	1.05	1.01	0.04	0.04	0.04	0.04	0.04	0.04	0.03
EVPerEBITDA_A EV Per EBITDA Ann.	-	-	-30.4	-42.5	-119.8	-0.1	1.7	3.3	9.5	6.3	9.7	7.2	5.3
MarketCapPerSales_A Market Cap Per Sales Ann.	210.7%	107.6%	27	30.9		0.9	0.3	0.7	1.5	1.5	4	1.6	0.7
RetentionRatios_A Retention Ratio Ann. %	-	-
EYield_A Earnings Yield Ann.	-	-	-0.1	-0.1	-0	-21.6		0.1	0.1	0	0	0	0.1
DEBT_CE_A Total Debt to Total Equity Ann.	27%	112.2%	4.3	3.4	3	2.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Current Ratio Ann.

5Y CAGR

-43.3%

7Y CAGR

-40%

10Y CAGR

-34.3%

Current Ratio Annual is falling faster than historical averages.

Celestial Biolabs cash flow: net, operating, investing, and financing flows as of Mar 2023 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Celestial Biolabs Mar-2023 Cash From Operating Activity is Rs -0 Cr which is growth of -25.6% YoY.
POSITIVE
Net Cash Flow Celestial Biolabs Mar-2023 Net Cash Flow is Rs 0 Cr which is growth of 178.6% YoY.

Celestial Biolabs Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16	Mar '15	Mar '14	Mar '13
CFO_A Cash from Operating Act. Ann. ⌄	-	-	-0.4	-0.3	-0	-3.1	16.7	3.3	13.4	8	7.8	3.3	4.5
PBT_A PBT Ann.	-	-	-0.6	-0.4	-0.2	-99.8	1.4	4.1	3.7	1.9	1.2	0.6	0.3
INT_A Interest Ann.	-	-				1.4	1.3	0	0	1.3	4.2	2.2	0.7
TAX_A Tax Ann.	-	-				-1.4	1.4	0.7	0.3	-0.2	-0.1	-0.3	-0.4
CFI_A Cash from Investing Act. Ann.	-	-	-0			4.1	-18.7	-4.9	-13.9	-11.6	-5.6	-8.2	-6.4
CFA_A Cash from Financing Act. Ann.	-	-18.3%	0.4	0.3	0.1	-1.1	2.1	1.1	-0	3.7	-1.9	5.3	1.9
NCF_A Net Cash Flow Ann. ⌄	-	-	0	-0	0	-0	0	-0.4	-0.5	0.1	0.3	0.4
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-	-		0	0	0.1	0	0.4	0.9	0.9	0.6	0.2	0.2
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-	-	0		0	0	0.1	0	0.4	0.9	0.9	0.6	0.2

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Financing Act. Ann.

1Y CHG

33.3%

2Y CAGR

100%

5Y CAGR

-18.3%

7Y CAGR

-27.2%

10Y CAGR

-14.4%

Cash from Financing Annual Activity growth is stable compared to historical averages.

Celestial Biolabs investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

Celestial Biolabs quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents